Global X China Biotech ETF (HKD)
Global X China Biotech ETF (HKSE: 2820) is an exchange-traded fund listed on the Hong Kong Stock Exchange, trading at HK$74.72 (about ₹914 a unit) as of 25 Sep 2026, 2:11 AM ET. It has an expense ratio of 0.68% and holds 30 securities. Indian residents can buy 2820 through Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$74.44
Today's high
HK$74.72
52 week low
HK$56.70
52 week high
HK$84.50
2820 opened at HK$74.46, closed previously at HK$74.72, and has traded between HK$56.70 and HK$84.50 over the past 52 weeks.
About
The Global X China Biotech ETF strives to achieve investment returns that closely mirror the performance of its designated benchmark index, prior to the subtraction of any fees and expenses.
Key statistics
Expense ratio
0.68%
Assets (AUM)
HK$693.6M
Holdings
30
NAV
HK$74.58
Avg. volume
—
1-year price change
-6.58%
5-year price change
-35.39%
Price change excludes dividends.
Top 10 holdings
2820 holds 30 securities in total. These 10 are 68.8% of the fund.
Where the money is invested
Countries
How to buy 2820 from India
Indian residents can buy 2820 units through Paasa in three steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the units are held in your own name with Interactive Brokers.
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Search 2820 and buy
Find the fund by its ticker, 2820, on the Hong Kong Stock Exchange, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Read the full guide: how to invest in 2820 from India
Trading and taxes when buying 2820 from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation. Gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Custody. Units are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
What is the 2820 price today?
Global X China Biotech ETF (2820) last traded at HK$74.72 on the Hong Kong Stock Exchange, as of 25 Sep 2026, 2:11 AM ET. That is ₹914 a unit at the 25 Sep 2026 HKD/INR rate.
When does 2820 trade, in Indian time?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
How big is 2820, and what does it cost to hold?
Global X China Biotech ETF manages about HK$693.6M. Its expense ratio is 0.68% a year, deducted inside the fund. It launched in 2019.
What are 2820's largest holdings?
The top three are WUXI BIOLOGICS CAYMAN INC (11.3%), WUXI APPTEC (11.0%) and BEONE MEDICINES-ADR (9.9%). 2820's 10 largest positions make up 68.8% of the fund.
How are gains on 2820 taxed in India?
Units held for more than 24 months are long-term and taxed at 12.5% without indexation; units held for 24 months or less are taxed at your income-tax slab rate. The gain is worked out in rupees, so the currency move counts.
Can I buy fractional units of 2820?
No. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How has 2820 performed?
2820's price is down 6.6% over the past year and down 35.4% over five years. These figures are price change only and exclude dividends; past performance does not guarantee future returns.